Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
save search
Display Week 2022 Showcasing CEO Forum and Women in Tech
Published: 2022-03-18 (Crawled : 08:00) - prnewswire.com
WISA | $9.675 8616.22% 98.85% 880K
|
Electronic Technology
|
| O: 0.0%
H: 3.39%
C: 0.0%
INTC | News | $28.155 -6.43% -7.46% 150M
|
Electronic Technology
|
| O: 1.17%
H: 0.0%
C: 0.0%
ceo women
WiSA Technologies Announces Closing of Previously Announced $7.6 Million Public Offering
Published: 2022-12-01 (Crawled : 22:00) - feed.businesswire.com
WISA | $9.675 8616.22% 98.85% 880K
|
Electronic Technology
| Email alert
Add to watchlist
offering
Permex Petroleum Corporation Interview to Air on Bloomberg U.S. on the RedChip Money Report®
Published: 2022-11-30 (Crawled : 13:00) - globenewswire.com
OILS | $ 0%
|
n/a
| Email alert
Add to watchlist
OILCD | $2.41 2786.23%
|
n/a
| Email alert
Add to watchlist
OILCF | $3.24 0
|
n/a
| Email alert
Add to watchlist
report air corporation
Permex Petroleum Corporation Postpones Listing on NYSE American
Published: 2022-11-16 (Crawled : 13:00) - globenewswire.com
OILCF | $3.24 0
|
n/a
| Email alert
Add to watchlist
OILCD | $2.41 2786.23%
|
n/a
| Email alert
Add to watchlist
OILS | $ 0%
|
n/a
| Email alert
Add to watchlist
corporation
Marker Therapeutics to Present Multi-Tumor-Associated Antigen (mTAA)-Specific T Cell Manufacturing Robotics Data at the 2021 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Published: 2021-04-27 (Crawled : 00:00) - prnewswire.com
MRKR | $3.1 778.69% 88.62% 160K
|
Consumer Services
|
| O: 0.0%
H: 10.53%
C: 8.91%
therapy t-cell
Marker Therapeutics Reports First Quarter 2021 Operating and Financial Results
Published: 2021-05-12 (Crawled : 22:00) - biospace.com/
MRKR | $3.1 778.69% 88.62% 160K
|
Consumer Services
|
| O: -0.85%
H: 3.42%
C: -7.69%
financial results results therapeutics
Increased R&D Activities Have Fueled Growth and Promise for Pancreatic Cancer Treatment
Published: 2021-05-20 (Crawled : 13:00) - prnewswire.com
TRIL | $18.44 0%
|
Health Technology
|
| O: 0.12%
H: 1.97%
C: -2.32%
SEEL | $0.812 -3.02% -3.12% 570K
|
Health Technology
|
| O: -3.36%
H: 6.96%
C: 4.43%
ONCY | $1.825 3.69% 3.56% 110K
|
Health Technology
|
| O: 4.24%
H: 5.93%
C: 3.73%
MRKR | $3.1 778.69% 88.62% 160K
|
Consumer Services
|
| O: -0.42%
H: 7.14%
C: 5.88%
ATNX 4 | $0.1904 2.37% 2.31% 1.4M
|
Health Technology
|
| O: -0.2%
H: 0.79%
C: -5.12%
treatment cancer growth pancreatic pancreas
Marker Therapeutics Announces Completion of New Manufacturing Facility to Support Clinical Development of MultiTAA-Specific T Cell Therapy Product Candidates
Published: 2021-01-13 (Crawled : 15:00) - biospace.com/
MRKR | $3.1 778.69% 88.62% 160K
|
Consumer Services
|
| O: 8.85%
H: 2.39%
C: -0.48%
therapy ev t-cell
Marker Therapeutics Announces FDA Lifted Partial Clinical Hold on Phase 2 AML Clinical Trial
Published: 2021-01-05 (Crawled : 15:00) - biospace.com/
MRKR | $3.1 778.69% 88.62% 160K
|
Consumer Services
|
| O: 18.37%
H: 25.86%
C: -0.57%
fda trial phase 2 clinical hold
Marker Therapeutics Announces Dosing of First Patient in Phase 2 Trial of MT-401 in Acute Myeloid Leukemia Following Stem Cell Transplant
Published: 2021-03-03 (Crawled : 19:00) - biospace.com/
MRKR | $3.1 778.69% 88.62% 160K
|
Consumer Services
|
| O: 3.2%
H: 4.26%
C: 0.39%
phase 2 myeloid leukemia stem cell leukemia trial acute myeloid leukemia
Marker Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
Published: 2021-03-11 (Crawled : 22:00) - biospace.com/
MRKR | $3.1 778.69% 88.62% 160K
|
Consumer Services
|
| O: 0.0%
H: 2.39%
C: 0.8%
offering therapeutics publication
Marker Therapeutics Reports Fiscal Year 2020 Operating and Financial Results
Published: 2021-03-09 (Crawled : 23:00) - biospace.com/
MRKR | $3.1 778.69% 88.62% 160K
|
Consumer Services
|
| O: 6.81%
H: 2.54%
C: 0.0%
financial results results therapeutics
Marker Therapeutics, Inc. Announces Closing of Public Offering of Common Stock
Published: 2021-03-16 (Crawled : 21:00) - prnewswire.com
MRKR | $3.1 778.69% 88.62% 160K
|
Consumer Services
|
| O: 0.54%
H: 3.21%
C: 0.53%
offering
Marker Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock
Published: 2021-03-12 (Crawled : 17:00) - biospace.com/
MRKR | $3.1 778.69% 88.62% 160K
|
Consumer Services
|
| O: -28.06%
H: 8.24%
C: 6.59%
offering
Marker Therapeutics to Present at the Virtual Oppenheimer 31st Annual Healthcare Conference
Published: 2021-03-15 (Crawled : 12:00) - biospace.com/
MRKR | $3.1 778.69% 88.62% 160K
|
Consumer Services
|
| O: 1.55%
H: 0.0%
C: -3.55%
conference
Marker Therapeutics to Present at the Virtual Raymond James Human Health Innovation Conference
Published: 2021-06-16 (Crawled : 22:00) - biospace.com/
MRKR | $3.1 778.69% 88.62% 160K
|
Consumer Services
|
| O: -0.78%
H: 4.38%
C: 1.87%
conference health
Marker Therapeutics Announces Completion of Safety Lead-In Portion of Phase 2 Study in Post-Transplant AML
Published: 2021-07-06 (Crawled : 12:00) - biospace.com/
MRKR | $3.1 778.69% 88.62% 160K
|
Consumer Services
|
| O: 2.29%
H: 2.41%
C: -5.17%
phase 2
Marker Therapeutics Awarded $13.1 Million Grant from the Cancer Prevention and Research Institute of Texas
Published: 2021-08-19 (Crawled : 00:00) - biospace.com/
MRKR | $3.1 778.69% 88.62% 160K
|
Consumer Services
|
| O: -1.69%
H: 3.45%
C: -3.45%
cancer research granted grant
Marker Therapeutics Reports Second Quarter 2021 Operating and Financial Results
Published: 2021-08-10 (Crawled : 20:00) - prnewswire.com
MRKR | $3.1 778.69% 88.62% 160K
|
Consumer Services
|
| O: -1.24%
H: 0.76%
C: -0.25%
financial results results therapeutics
Marker Therapeutics Announces that Data from Investigator-Sponsored Phase 1 Study With its MultiTAA-Specific T Cells to be Presented at the 2021 American Society of Hematology Annual Meeting
Published: 2021-11-18 (Crawled : 22:00) - biospace.com/
MRKR | $3.1 778.69% 88.62% 160K
|
Consumer Services
|
| O: 0.0%
H: 0.74%
C: -7.35%
ema phase 1 t-cell
Gainers vs Losers
| 66% | 34% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.